Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020068163 - METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT

Publication Number WO/2020/068163
Publication Date 02.04.2020
International Application No. PCT/US2019/028553
International Filing Date 22.04.2019
IPC
A61K 31/232 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
23of acids having a carboxyl group bound to a chain of seven or more carbon atoms
232having three or more double bonds, e.g. etretinate
A61K 45/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K 47/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
CPC
A61K 31/232
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
23of acids having a carboxyl group bound to a chain of seven or more carbon atoms
232having three or more double bonds, e.g. etretinate
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K 47/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Applicants
  • AMARIN PHARMACEUTICALS IRELAND LIMITED [IE]/[IE]
  • SONI, Paresh [US]/[US] (US)
Inventors
  • SONI, Paresh
Agents
  • GALLAGHER, Audrey T.
Priority Data
62/735,67024.09.2018US
62/735,68024.09.2018US
62/758,35709.11.2018US
62/813,88805.03.2019US
62/818.51414.03.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT
(FR) PROCÉDÉS DE RÉDUCTION DU RISQUE D'ÉVÉNEMENTS CARDIOVASCULAIRES CHEZ UN SUJET
Abstract
(EN)
In various embodiments, the present disclosure provides methods reducing the risk of cardiovascular events in a subject on statin therapy by administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.
(FR)
Dans divers modes de réalisation, la présente invention concerne des procédés de réduction du risque d'événéments cardiovasculaires chez un sujet sous traitement par statine par l'administration au sujet d'une composition pharmaceutique comprenant environ 1 g à environ 4 g d'éthylester de l'acide eicosapentaénoïque ou d'un dérivé de celui-ci.
Also published as
CA3042062
Latest bibliographic data on file with the International Bureau